This page was translated automatically from Turkish. Read the original

This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it.

Deep brain stimulation for OCD: the Amsterdam experience and cross-cultural, gender, and minority dimensions of access to treatment

Dbs in ocd: the amsterdam experience with aspects of transcultural, gender and minority access to dbs

The world's largest single-center cohort receiving deep brain stimulation for OCD is being studied not only for treatment effectiveness but also to understand who can access this treatment.

Deep brain stimulation (DBS) has been used for treatment-resistant obsessive-compulsive disorder (OCD) at Amsterdam UMC for approximately 20 years; initially delivered within clinical trials, it has been available as reimbursed, evidence-based care since 2013. Although neuroanatomical targets and targeting methods have changed over time, eligibility criteria have remained largely unchanged. The clinical cohort currently comprises 120 patients, making it the world's largest single-center cohort receiving DBS for OCD; the center has also investigated DBS for treatment-resistant major depressive disorder and anorexia nervosa in clinical trials. As clinical experience has accumulated, questions have arisen not only about which patient characteristics are associated with different treatment outcomes, but also about who can access DBS. The presentation first summarizes the effectiveness of DBS for OCD, then examines the cohort's sociodemographic composition in terms of educational attainment, gender, and minority background to assess how well it represents the broader population of patients with severe, treatment-resistant OCD. The findings are interpreted in the context of wider inequalities in mental health care and the practical, clinical, and organizational barriers to implementing DBS as a psychiatric intervention; the final section discusses what is needed to ensure equitable access to DBS for severe psychiatric disorders, along with questions for future research and practice.

All WCP 2026 summaries